These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 16173520)

  • 1. Vaccine Refusal: A Major, Underestimated Obstacle for the Poliomyelitis Eradication Initiative.
    Seytre B
    Am J Trop Med Hyg; 2023 Jul; 109(1):6-9. PubMed ID: 37188348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New generation of inactivated poliovirus vaccines for universal immunization after eradication of poliomyelitis.
    Chumakov K; Ehrenfeld E
    Clin Infect Dis; 2008 Dec; 47(12):1587-92. PubMed ID: 18990066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Global Polio Laboratory Network as a Platform for the Viral Vaccine-Preventable and Emerging Diseases Laboratory Networks.
    Diop OM; Kew OM; de Gourville EM; Pallansch MA
    J Infect Dis; 2017 Jul; 216(suppl_1):S299-S307. PubMed ID: 28838192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Consolidated Health Facility Masterlist Using Data From Polio Electronic Surveillance in the World Health Organization African Region.
    Babona Nshuti MA; Touray K; Muluh TJ; Ubong GA; Ngofa RO; Mohammed BI; Roselyne I; Oviaesu D; Bakata EMO; Lau F; Kipterer J; Green HHW; Seaman V; Ahmed JA; Ndoutabe M
    JMIR Public Health Surveill; 2024 Jun; 10():e54250. PubMed ID: 38904997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polio control after certification: major issues outstanding.
    Fine PE; Oblapenko G; Sutter RW
    Bull World Health Organ; 2004 Jan; 82(1):47-52. PubMed ID: 15106300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk management in a polio-free world.
    Bruce Aylward R; Sutter RW; Cochi SL; Thompson KM; Jafari H; Heymann D
    Risk Anal; 2006 Dec; 26(6):1441-8. PubMed ID: 17184391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Poliomyelitis surveillance in the Czech Republic from the start of vaccination to the certification of eradication in the European Region].
    Matyásová I
    Epidemiol Mikrobiol Imunol; 2005 Feb; 54(1):16-20. PubMed ID: 15807383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Global eradication of poliomyelitis. On the 80th anniversary of the founding of the National Institute of Health].
    Slonim D
    Epidemiol Mikrobiol Imunol; 2005 Aug; 54(3):99-108. PubMed ID: 16173520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of poliomyelitis--options and update.
    Dutta A
    Vaccine; 2008 Oct; 26(45):5767-73. PubMed ID: 18755232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [End phase challenges of poliomyelitis eradication programme realization].
    Jarzabek Z
    Przegl Epidemiol; 2005; 59(1):59-68. PubMed ID: 16013411
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.